Skip to search formSkip to main contentSkip to account menu

Anti-CEA Antibody

Known as: Anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 Antibody, CEA Antibody, Anti-CEACAM5 Antibody 
Any antibody against the tumor associated antigen carcinoembryonic antigen (CEA; CEACAM5), with potential antineoplastic activity. The CEA antigen is… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Solid tumors have a heterogeneous pathophysiology, which directly affects antibody-targeted therapies. Here, we consider the… 
Highly Cited
2006
Highly Cited
2006
Purpose: Antibody-directed enzyme prodrug therapy is a two-stage treatment whereby a tumor-targeted antibody-enzyme complex… 
Highly Cited
2003
Highly Cited
2003
PURPOSE With increasing interest in pretargeting procedures for improving the delivery of radionuclides for cancer imaging and… 
2002
2002
Antibody engineering has made it possible to design antibodies with optimal characteristics for delivery of radionuclides for… 
Highly Cited
2001
Highly Cited
2001
A simple, water-soluble procedure for conjugation of monoclonal antibodies to 1,4,7,10-tetraazacyclododecane-N,N',N",N… 
Highly Cited
2001
Highly Cited
1999
Highly Cited
1999
The irregular nature of solid tumor vasculature produces a heterogeneous distribution of antibody-targeted therapies within the… 
Highly Cited
1998
Highly Cited
1998
In the MD45 mouse cytotoxic T lymphocyte (CTL) hybridoma cell line, we have expressed a chimeric receptor, consisting of the… 
Highly Cited
1996
Highly Cited
1996
A novel engineered antibody fragment (VL-VH-CH3, or "minibody") with bivalent binding to carcinoembryonic antigen (CEA) was…